Inhibition of the intestinal FXR-SMPD3 axis has been shown to improve atherosclerosis (21), while activation of TGR5 can inhibit atherosclerosis by reducing macrophage inflammation and lipid accumulation (22). This evidence concerns the gene NR1H4 and atherosclerosis.